Navigation Links
SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research
Date:7/31/2014

COLORADO SPRINGS, Colo., July 31, 2014 /PRNewswire-USNewswire/ -- The SNIS Foundation recognized its first Seed Grant awardee today with $25,000 to fund a translational research project.  The first award since the Foundation's inception in 2011, the gift was presented at the Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting in Colorado Springs, CO.

Representing physicians who specialize in neurointerventional approaches to neurovascular conditions, SNIS formed the SNIS Foundation, in part, to ensure investment in scientific research and discovery that enables practitioners to provide the highest level of care to patients who can benefit from neurointerventional treatment.  The Seed Grant is a one-year gift that enables young investigators (MDs, DOs, or MD-PhDs) to conduct pilot projects that address a specific hypothesis and generate preliminary data in preparation for major grant applications to corporations, foundations and governmental agencies.

The first recipient, Daniel Cooke, MD, Assistant Professor of Radiology and Biomedical Imaging at the University of California, San Francisco, was awarded the grant for his innovative work in facilitating first-time evaluation of endothelial cells harvested from  devices utilized in neurointerventional procedures to treat ruptured and unruptured aneurysms. By obtaining these tissue samples during a standard procedure, and analyzing genetic expression at the single cell level, Cooke and his team aim to advance neurointervention by utilizing their study of endothelial cells to offer insights into the mechanisms of aneurysm formation, evolution, and — in some cases — rupture.

"This is exciting and innovative work worthy of continued exploration and support from the SNIS Foundation," said Lee Jensen, MD, Professor of Radiology, Neurology an
'/>"/>

SOURCE Society of NeuroInterventional Surgery
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Reagan-Udall Foundation Announces New Board Chairman
2. Hepatitis B Foundation to Host Annual Crystal Ball Gala
3. New Jersey Health Foundation President Addresses Panel at AAHC Research Efficiency Conference
4. The Hartwell Foundation Welcomes Russell "Rusty" Hensley as New CEO
5. NeuroPhage Awarded Second Grant from Michael J. Fox Foundation for Parkinsons Disease Research
6. Russian Foundation of Basic Research Chooses Elseviers Scopus to Improve Russias Research Ranking Position
7. InterMune Announces Support of The Pulmonary Fibrosis Foundation Care Center Network and Patient Registry Initiative
8. Foundation for the NIH Launches Bone Quality Project
9. Cedar Crest College Awarded Significant Grant from the National Science Foundation
10. Biomedical Research Foundation (BRF) Recruits Two Eminent Scientists --Pradeep Garg, Ph.D., And Sudha Garg, Ph.D. -- To Run Newly-Created Louisiana Center For Molecular Imaging And Therapy
11. Boehringer Ingelheim to Sponsor the Bonnie J. Addario Lung Cancer Foundations Efforts to Promote Genetic Biomarker Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... has announced the addition of Jain PharmaBiotech,s new ... Companies" to their offering. This ... development of sequencing technologies, and their applications. Current ... as companies developing them. Various applications of sequencing ...
(Date:9/2/2015)... , Sep. 02, 2015 ... the addition of Jain PharmaBiotech,s new report "Gene ... offering. The markets for gene therapy are ... gene therapy product and it is marketed in ... are estimated for the years 2014-2024. The estimates are ...
(Date:9/2/2015)... Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., announced ... the multicenter Phase 2 clinical trial of NT-503 ... of recurrent subfoveal choroidal neovascularization secondary to age ... unique vascular endothelial growth factor (VEGF) receptor protein ... "This landmark proof-of-concept study will evaluate NT-503 ...
(Date:9/2/2015)... September 2, 2015 BioLight ... or the "Company"), a firm that invests in, ... cancer diagnostics, announced today that presentations highlighting its ... be delivered at the Ophthalmology Futures European Forum ... of Cataract & Refractive Surgeons ("ESCRS"), both taking ...
Breaking Biology Technology:Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that ... conference call and webcast on Wednesday, October 28, at 5:00 ... , U.S. / Canada Dial-in Number: ... Participant Code: 51404008, Replay Dial-in ...
... Calif., Sept. 30 MacuSight, a developer of ... conditions, today provided a clinical development update for Perceiva, the ... patient enrollment in four ongoing Phase 2 clinical trials of ... the first half of 2010. All four studies are ...
... a number of key issues such as land use and ... global use of biofuels is excepted to more than double ... released today by Hart,s Global Biofuels Center. Leading the expansion ... use of more than 35%. Brazil will grow domestic supplies ...
Cached Biology Technology:BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET 2MacuSight(R) Provides Clinical Development Update for Perceiva(TM) 2MacuSight(R) Provides Clinical Development Update for Perceiva(TM) 3MacuSight(R) Provides Clinical Development Update for Perceiva(TM) 4MacuSight(R) Provides Clinical Development Update for Perceiva(TM) 5Global Biofuels Growth to Double by 2015 2Global Biofuels Growth to Double by 2015 3Global Biofuels Growth to Double by 2015 4
(Date:8/4/2015)... Research and ... addition of the "Digital Forensics Market ... (Computer Forensics, Network Forensics, Mobile Device Forensics, ... and Region - Global Forecast to 2020" ... By Component (Hardware, Software, and Service), Sub-Segment ...
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... in the prestigious PLoS One journal changes our ... researchers found that degenerative changes and loss of vision are ... autophagy, in the fundus of the eye. The results ... of AMD, which currently lacks an efficient treatment. The University ...
... Monday following a big football game, fans of the ... and sugars, whereas supporters of the winning team opt ... Psychological Science , a journal of the Association ... that sport outcomes influence reckless driving, heart attacks, and ...
... 20, 2013  Today BluStor PMC, Inc. unveiled the ... protects the full stream of mobile security: device, ... what,s possible using BluStor, the company has launched ... http://www.blustor.com/whatspossible.php . (Logo:   http://photos.prnewswire.com/prnh/20130820/PH66368LOGO ) ...
Cached Biology News:Research breakthrough: Impaired autophagy associated with age-related macular degeneration 2For disappointed sports fans, defeats increase consumption of fat and sugar 2BluStor Introduces the World's First Platform to Protect the Full Stream of Mobile Security: Device, User, And Data 2
... DNA Polymerase I Large (Klenow) Fragment, ... that lacks both the 5´→3´ and the ... coli DNA Polymerase I (1,2). It is ... in strand displacement amplification (5). Klenow Fragment, ...
... one of several isoprostanes produced from arachidonic acid ... vasoconstrictor in the rat. 8-iso PGE2 inhibits U-46619 ... 0.5 and 5 µM, respectively. When infused into ... concentration of 4 mg/kg/min, 8-iso PGE2 decreases the ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... Centra-CL5R multi-purpose centrifuge offers both high-speed ... assortment of rotor options, making it ... applications., Maximum Versatility , High-speed ... angle rotors or high-volume (4 x 250mL) ...
Biology Products: